Age, Race Impact Prostate Cancer Risk
Prostate cancers detected during screening are much more likely to be high risk when they affect black men and men aged 75 years or older.Men over age 74 years were nine times more likely to have high-risk... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 16, 2013 Category: Cancer & Oncology Source Type: news

Survival Shorter in Young Gastric Cancer Patients
SAN FRANCISCO (IMNG) - Patients with gastric adenocarcinoma who were diagnosed before age 40 years died significantly sooner than did older patients, based on the results of a single-center, retrospective... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 16, 2013 Category: Cancer & Oncology Source Type: news

Race Effects On Gastric Cancer Prognosis Have Evolved
SAN FRANCISCO (IMNG) - Race is a significant predictor of the odds of surviving gastric cancer at the time of diagnosis: Its impact lessens the longer the patient survives, an analysis of data on 24,657... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 16, 2013 Category: Cancer & Oncology Source Type: news

Capecitabine Chemoradiotherapy Effective in Local Pancreatic Cancer
SAN FRANCISCO (IMNG) - Following induction chemotherapy with radiotherapy plus capecitabine seemed to be equally effective and less toxic compared with following with radiotherapy plus gemcitabine in a... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 16, 2013 Category: Cancer & Oncology Source Type: news

No Early Cancer Risk With Donor Lungs From Heavy Smokers
LOS ANGELES (IMNG) - Use of lungs from donors who smoked heavily does not worsen lung transplantation outcomes including risk for lung cancer death, at least in the medium term.At a median follow-up of... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 15, 2013 Category: Cancer & Oncology Source Type: news

Assay May Target Early Lung Cancers for Adjuvant Therapy
LOS ANGELES (IMNG) - A novel genetic assay helps identify patients with early, aggressive lung cancer who might benefit from adjuvant therapy.The assay, marketed as Pervino Lung RS by Life Technologies,... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 15, 2013 Category: Cancer & Oncology Source Type: news

Gene Profiling Predicted Responses to Colorectal, Pancreatic Cancer Treatment
SAN FRANCISCO (IMNG) - Gene expression profiling of patients with colorectal cancer and pharmacogenomic modeling of patients with pancreatic cancer could help identify which patients will respond to particular... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 14, 2013 Category: Cancer & Oncology Source Type: news

Breast-Conserving Therapy Improved Survival over Mastectomy
Women who underwent lumpectomy for stage I or II breast cancer were 28% less likely to die from any cause and up to 16% less likely to die from breast cancer, compared with women who underwent mastectomy,... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 14, 2013 Category: Cancer & Oncology Source Type: news

Diversity of Triple-Negative Breast Cancer Complicates Treatment
Treatment of triple-negative breast cancer, so named because it lacks estrogen receptors, progesterone receptors, and HER2 overexpression, is one of the most challenging areas of breast oncology. Not only... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 14, 2013 Category: Cancer & Oncology Source Type: news

FDA Approves Pomalidomide for Advanced Multiple Myeloma
Pomalidomide has been approved for the treatment of patients with multiple myeloma whose disease has progressed after treatment with at least two prior therapies, including lenalidomide and bortezomib,... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 12, 2013 Category: Cancer & Oncology Source Type: news

Bevacizumab Plus Chemo Extends Survival in Metastatic Cervical Cancer
Adding bevacizumab to chemotherapy extended survival by about 4 months beyond the survival achieved with chemotherapy alone in chemotherapy-naïve patients with persistent, recurrent, or metastatic cervical... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 12, 2013 Category: Cancer & Oncology Source Type: news

Screen Asymptomatic Siblings of CRC Patients
Asymptomatic siblings of Chinese colorectal cancer patients are at threefold higher risk for advanced colorectal neoplasms and at twofold higher risk for any colorectal adenoma, compared with siblings... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 12, 2013 Category: Cancer & Oncology Source Type: news

New Adjuvant to Surgery Improved Pancreatic Cancer Survival
SAN FRANCISCO (IMNG) - Japanese patients who underwent surgery for pancreatic cancer were 44% less likely to die within 2 years if they were treated postoperatively with the chemotherapy drug S-1, compared... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 12, 2013 Category: Cancer & Oncology Source Type: news

Folic Acid Supplements Have no Effect on Cancer Rates
Taking folic acid supplements neither increases nor decreases the incidence of cancer during the treatment period, according to a meta-analysis of 13 large randomized controlled trials that examined this... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 11, 2013 Category: Cancer & Oncology Source Type: news

Cancer Survival Still Lower for African Americans
The 5-year cancer survival rate for African Americans has risen 54% since the 1970s, but continues to be lower than that of whites, according to a report from the American Cancer Society.Data from the... (Source: OncologySTAT Latest News)
Source: OncologySTAT Latest News - February 9, 2013 Category: Cancer & Oncology Source Type: news